<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Elderly patients constitute a subpopulation with special clinical features that differ from those of the general population and are under-represented in clinical trials </plain></SENT>
<SENT sid="1" pm="."><plain>We retrospectively analyzed the toxicity and efficacy of <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi>-based chemotherapy in the treatment of elderly patients affected by metastatic (m) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Seventy-five consecutive patients aged 65-75 years (median age 71 years), 51 males and 24 females, with mCRC and <z:e sem="disease" ids="C1513041" disease_type="Disease or Syndrome" abbrv="">measurable disease</z:e>, were analyzed </plain></SENT>
<SENT sid="3" pm="."><plain>The primary site of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> was the liver (38.6% of patients) </plain></SENT>
<SENT sid="4" pm="."><plain>The majority of patients had a performance status (PS) according to the Eastern Cooperative <z:hpo ids='HP_0002664'>Oncology</z:hpo> Group (ECOG) PS before treatment of 0-1 (96%) </plain></SENT>
<SENT sid="5" pm="."><plain>The overall response rate was 57.3%, median progression-free survival was 7 months and median overall survival was 27 months </plain></SENT>
<SENT sid="6" pm="."><plain>The main hematological and extra-hematological toxicities (grade 3 or 4) were <z:hpo ids='HP_0001875'>neutropenia</z:hpo> (20.0%), and neurological toxicity or <z:hpo ids='HP_0002014'>diarrhea</z:hpo> (6.7%), respectively </plain></SENT>
<SENT sid="7" pm="."><plain>No toxic <z:hpo ids='HP_0011420'>death</z:hpo> occurred </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="0" ids="31941">Oxaliplatin</z:chebi>-based chemotherapy maintains its efficacy, and safety in elderly patients with mCRC and good PS </plain></SENT>
<SENT sid="9" pm="."><plain>This regimen should be considered in the treatment of this particular setting of patients </plain></SENT>
</text></document>